Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Discovery Life Sciences (DLS) is a global leader in biospecimen solutions and multi-omic services, providing high-quality biological materials and analytical support to the pharmaceutical and biotechnology industries. The company maintains the world's largest commercial biospecimen inventory and a vast global procurement network, offering ethically sourced tissue, blood, and cell products. Complementing its specimen offerings, Discovery provides comprehensive laboratory services in genomics, proteomics, molecular pathology, and flow cytometry. These integrated capabilities enable researchers to accelerate drug discovery and diagnostic development through precise biomarker identification and clinical trial support. With specialized divisions like AllCells, the company also provides GMP-compliant materials essential for cell and gene therapy research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Discovery Biosciences.